Matrix metallopeptidase 16 mRNA 3'-untranslated region (MMP16 mRNA 3'-UTR)

The Matrix metallopeptidase 16 (MMP16) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the MMP16 transcript, which encodes a membrane-type matrix metalloproteinase also known as MT3-MMP (UniProt P51512). This region serves as a scaffold for the binding of various microRNAs (miRNAs), such as miR-146b and miR-505, and RNA-binding proteins that dictate the half-life and translational efficiency of the mRNA (Xia et al., 2011, Cancer Research). In many cancers, including glioblastoma, melanoma, and lung adenocarcinoma, the regulatory control exerted by this 3'-UTR is often bypassed or disrupted, leading to the pathological overexpression of the MMP16 protein (Chen et al., 2017, Molecular Medicine Reports). High levels of MMP16 facilitate the degradation of the extracellular matrix and promote epithelial-mesenchymal transition, thereby driving tumor cell invasion and metastasis. Because of its central role in post-transcriptional gene silencing, the MMP16 mRNA 3'-UTR is considered a significant therapeutic target for RNA-based interventions. Experimental strategies often involve the use of miRNA mimics or antisense oligonucleotides designed to bind this region and suppress the production of the pro-tumorigenic MMP16 enzyme. However, therapeutic development faces challenges such as ensuring target specificity to avoid off-target silencing and achieving efficient delivery to tumor tissues.

Other names

MT3-MMP mRNA 3'-UTRMatrix metalloproteinase 16 mRNA 3'-UTRMMP16 3'-UTRMMP16 3'-untranslated region

MicroRNA-mediated gene silencing and translational repression